The clinical observation of bevacizumab combined with vitrectomy and triamcinolone acetonide treat proliferative diabetic retinopathy

Gai-li Zhang, Yin-bo Fan, Yun Xiao, Lan Qu, Xue-hong Cai, Zhenghua Xu, Xiao‐Wei GaoChinese 2012 · DOI

Abstract

Objective To observe the visual function and the condition of complication happened after bevacizumab combined with vitrectomy and triamcinolone acetonide treat proliferative diabetic retinopathy (PDR) and to analyze the clinical effect and advantage of three methods together retrospectively.Methods Ninety-eight eyes of PDR patients were divided into two groups,the experiment group 52 eyes,the control group 46 eyes,no surgical contraindication by general physical checkup.All two groups accepted standard plan par vitrectomy,stripping of membrane and intraocular photocoagulation.Experiment group received intravitreal administration of bevacizumab (Avastin 1.25 mg) before surgery after accepting the patients' content,operating vitrectomy in the seventh day,intravitreal administrated triamcinolone (2 mg) at the end of diabetic vitrectomy,semireclining position 6-8 hours postoperative.The control group only intravitreal administrated triamcinolone (2 mg) at the end of diabetic vitrectomy.Main outcome measures were operation time,intraocular pressure (IOP),macular thickness and best-corrected visual acuity (BCVA).Results In the course of operation and strip membrane,the membranes stripped easily and hemorrhage reduced obviously intraoperative in the experiment group,the control group strip difficulty and time-consuming,the operation time were statistical significance between two groups (t =28.50,P =0.000).The IOP were not statistical significance in the first week,the first,the third and the sixth month after operation (t =0.664,0.852,0.742,0.110,P =0.515,0.406,0.468,0.914).The macular thickness were statistical significance in the second week after operation (t =5.665,P =0.000),but were not statistical significance in the first,the third and the sixth month after operation (t =0.590,0.984,1.292,P =0.563,0.388,0.213).Visual acuity elevate to some extent contrast to preoperative,the experiment group were 12 eyes ≤0.02,11 eyes ≤0.05,16 eyes ≤0.3,13 eyes >0.3; the control group were 11 eyes ≤0.02,12 eyes ≤0.05,14 eyes ≤0.3,9 eyes >0.3.Conclusions Intravitreal administrated bevacizumab prior to vitrectomy facilitates vitrectomy procedures,strip membrane easily,reduces hemorrhage intraoperative and rehaemorrhagia postoperative,combined with intravitreal administrated triamcinolone acetonide relieve the reaction of anterior chamber and vitroues postoperative,and relieve macular edema,thus improving the visual function. Key words: Bevacizumab; Vitrectomy; Triamcinolone acetonide; Proliferative diabetic retinopathy
BibTeX
@inproceedings{zhang2012clinical,
  author = {Gai-li Zhang and Yin-bo Fan and Yun Xiao and Lan Qu and Xue-hong Cai and Zhenghua Xu and Xiao‐Wei Gao},
  title = {{The clinical observation of bevacizumab combined with vitrectomy and triamcinolone acetonide treat proliferative diabetic retinopathy}},
  booktitle = {Chinese},
  year = {2012},
  doi = {10.3760/cma.j.issn.1006-4443.2012.12.024},
}

Loading related content...

Figure